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Several attempts have been made in recent years to study the antigenic con- 
stituents of amyloid and purified amyloid fibrils (1-5). Depending on the state 
of purity  of the  antigens used for immunization,  one or more serum proteins 
have  been  identified  in  all  such  preparations.  Among  these  are "},-globulins, 
lipoproteins,  certain  complement  components,  and  a  number  of  ~1  and  a2 
globulins. The purest of these preparations induced the formation of antibodies 
to  only  one  substance,  the  "P  component,"  which  is  an  al  globulin  with  a 
sedimentation coefficient between 7 and 19S present in normal serum but not in 
nonamyloid  tissues  (6).  The  "P  component"  appears  to  correspond  to  the 
pentagonal structures,  also known as rods or doughnuts,  reported by Glenner 
et al (7). The "P component" does not constitute a  major constituent of amy- 
loid  since  in  preparations  of  amyloid fibrils  containing  large  amounts  of the 
component,  only a  small fraction of the protein was precipitable by the  anti- 
serum (5, 6). 
The recent demonstration that the major constituent of amyloid is a fibrillar 
protein  (8)  may be the reason why amyloid has proven to be poorly immuno- 
genic and why it has been difficult to obtain antibodies specifically reactive with 
amyloid (3,  5).  The availability of purified water-soluble amyloid fibrils from 
nine patients with amyloidosis (9, 10) has permitted a series of studies designed 
not only to characterize the major antigenic constituents of amyloid, but also to 
determine whether these are unique to amyloid or whether they are present also 
in normal serum or tissues. In addition, it has been possible to compare amyloid 
fibrils  isolated  from  different  subjects  and,  in  two  instances,  from  different 
tissues from the same subject. The results of these studies permit the following 
tentative conclusions. Firstly, the major antigenic constituent of amyloid fibrils 
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is a  protein unique to amyloid and not present  in normal  serum,  in normal  tis- 
sues,  or in serum from patients with amyloidosis. In its native fibrillar form, this 
material  appears  to be poorly immunogenic or possibly even nonimmunogenic. 
However,  after  degradation  with  sodium  hydroxide,  the  material  from  most 
amyloid  preparations  induced  the  formation  of  antibodies  in  rabbits  (11). 
Secondly,  different  preparations  of amyloid  show varying degrees  of antigenic 
cross-reaction,  while each appears  to contain  additional  antigenic determinants 
that  distinguish  it from the others  (12).  Taken  together  with  the physical  and 
chemical characterization in the accompanying article (10), these results suggest 
that  amyloids from different individuals  are a  series of closely related,  but  not 
identical substances.  Because of the complexity of these proteins,  a  larger num- 
ber of antisera  and  amyloid preparations  will have to be tested to permit defi- 
nite conclusions regarding the existence of well defined classes and subclasses  of 
amyloid. 
Materials and Methods 
Soluble A myloid and Degraded Amyloid (DAM).-Preparations of anayloid  were the same 
as were used in the preceding article (10). DAM was prepared from each of these by treatment 
with 0.1 ~  NaOH, followed by prolonged dialysis against distilled water. 
[mmunization.--In  the initial phases of this study, four rabbits were immunized subcutan- 
eously with a  mixture of amyloid  1 in Freund's adjuvant at weekly or biweekly intervals. 
Numerous  bleedings tested  by complement fixation against  amyloid and  DAM during a  9 
month period failed to demonstrate antibody.  By precipitin analysis,  two of these antisera 
gave a  faint precipitin line on immunoelectrophoresis with about  one-half of the available 
preparations  of aged amyloid, but never with fresh preparations  of amyloid or DAM. The 
reactive antigenic component had a mobility slower than T-globulin, but defied further identi- 
fication.  Because of the weakness of these antisera and  the ill-defined  nature of the material 
reacting with them on immunoelectrophoresis, we used DAM as the immunizing antigen in 
subsequent experiments in the hope of producing stronger antisera reactive with amyloid and 
DAM. It seems possible  that amyloid is poorly immunogenic because of the general observa- 
tion that fibrous proteins retaining their native structure often elicit a poor antibody response 
(3, 5). 
At least  two  rabbits  were immunized  by  the same procedure with each of eight DAM 
preparations.  DAM  1,  2,  5,  6,  9,  and  10 proved  to be excellent antigens and  induced  the 
formation of significant amounts of antibody within 2-3 months. DAM 3 and 8 have failed to 
induce an immune response after 9- and 5-month courses of immunization respectively. 
Immunologic Methods.  All antisera were inactivated at 56  ° for 30 min and absorbed with 
normal human serum and either normal spleen  or liver homogenates. Antibody activity was 
tested for in the following ways: 
1. Qualitative determinations of antibody were done by immunoelectrophoresis (13) or by 
double diffusion  in agar using Ouchterlony's method (14). 
2. Quantitative precipitin  analyses  were done according  to  the method  of  Heidelberger 
(15). In tests involving precipitation, only DAM could be used as the test antigen because of 
the insolubility of amyloid in solvents containing even trace amounts of salt (9). Since amyloid 
proved to be reactive with these antisera, it was possible  to use it for absorption studies de- 
signed to compare the antigenic relationship of amyloid and DAM by quantitative analysis. 
Absorption of the antisera was carried out by the addition of amvloid in distilled water to the EDWARD C.  FRANKLIN AND  MORDECHAI PRAS  799 
antisera. In general, amounts up to 50 times the amount of DAM were employed. It was not 
important to avoid the region of antigen excess where one commonly encounters solubilization 
of complexes, since the antigen used for absorption was insoluble under the conditions of the 
experiment and thus behaved as an insoluble immunoadsorbent. A large flocculent precipitate 
formed immediately after the addition of amyloid and was removed in the Spinco Model L 
ultracentrifuge (Beckman Instruments, Inc., Spinco Division, Fullerton, Calif.) by centrifuga- 
tion at 10,000 rpm for 30 min. An equal amount of distilled water was added to the unabsorbed 
antiserum used for comparison. A control to detect possible nonspeeific removal of antibody 
y-globulin from the antiserum was carried out by the addition of amyloid to an antiserum to 
human ")'-globulin. 
3. Complement fixation was done according to the method of Mayer  (16), using approxi- 
mately 40-60 C'Hs0 units of guinea pig complement. Since  not all tests with each antiserum 
were done simultaneously, the results are expressed as per cent of complement fixed, for ease 
of comparison. Because antigens need not be in solution for complement-fixation tests, both 
amyloid and DAM could be used as antigens and tested directly. 
Radioactive Labellng.--To  increase the sensitivity of the precipitin tests with some of the 
early bleedings from the rabbits  immunized with DAM  1 and to get a clearer idea of the 
fraction  of DAM precipitated  by the  antisera,  we labeled DAM  1 with 125I, using iodine 
monochloride (17)1 The amyloid from which this DAM was made appeared homogeneous on 
ultracentrifugal  analysis. By this criterion, it was probably at least 90% pure. The amount 
of radioactivity precipitated was measured in a pulse height analyzer. 
RESULTS 
Nature  of  Antisera  and  Antigens.--Figure  1  a  shows  the  immunoelectro- 
phoretic pattern of DAM 1 and DAM 5 and their homologous antisera. Similar 
patterns were also noted with each of the other preparations on immunoelectro- 
phoresis.  In the fresh state,  each preparation migrated slightly to the  anodal 
side of the point of application. After prolonged storage in the cold, however, 
the mobility of several of these preparations changed and the major component 
migrated in the region of the slow "},-globulins.  The lower half of the slides in- 
dicates that these antisera, even prior to absorption, failed to react with either 
normal human serum or an extract of spleen. Since some of the antisera gave a 
weak reaction with either a tissue extract or normal human serum, all antisera 
were absorbed with a  mixture of NHS  and a  saline extract of the tissue from 
which the amyloid was extracted prior to use. 
Figure 1 b shows an Ouchterlony plate, indicating that a representative anti- 
serum gives  a  single precipitin line with  DAM  but fails to  react  with NHS, 
spleen, 7G globulin, Fab, and Fc fragments. While six of eight antisera produced 
precipitin lines with the homologous antigen, none gave a  precipitin line with 
any other DAM preparations. This appears to be due to the lack of sensitivity 
of the method, since significant cross-reaction was noted by quantitative precipi- 
tation and complement-fixation tests. 
Since the possibility remained that the reaction was due to a minor contami- 
nant associated  with  the  fibrils rather  than  to  a  reaction between antibody 
t We would like to thank Dr. Marcus Rothschild for making this preparation for us. FIG.  1 a.  Immunoelectrophoretic patterns of DAM  1 and DAM 5  (D-1  and  D-5), normal 
human serum  (NHS),  and normal spleen extract  (SP). Top, antiserum 210  to DAM  1;  bot- 
tom,  antiserum  231  to  DAM  5.  1 b.  Ouchterlony analyses, comparing reactions of DAM  2 
(D), NHS,  liver extract  (L), 3'G globulin  (G),  Fc  fragment  (Fc), and  Fab  fragment  (Fab) 
with Antiserum 212  neat (N)  and absorbed with an excess of liver extract and serum  (A) in 
the center wells. 
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and fibrils, 1 ml of each of the antisera was absorbed with a powder prepared 
by lyophilization of 1 ml NHS, 1 ml of sodium hydroxide-treated serum, and 
an aqueous  extract prepared from 400 mg dry tissue, half of which was  also 
treated with 0.1 M sodium hydroxide. As shown in Figure 1 b, there was no dim- 
inution in the precipitin line after such  exhaustive absorption.  Similarly, the 
amyloid fibrils and DAM preparations failed to react with antisera to albumin, 
T-globulins, al  and ~2 globulins, and C-reactive protein. 
To further  characterize the  antigen  and  to  determine  what  fraction pre- 
cipitated with the  antiserum,  we precipitated  the 125I-labeled preparation  of 
DAM 1 with the homologous antiserum. 87 % was precipitable with 10% TCA, 
and 55 %  was precipitated by the antiserum at equivalence. Thus, more than 
63 % of the TCA-precipitable antigen was precipitated by the antiserum. It is 
not  possible  to  determine whether  the  nonprecipitable fraction represents  a 
nonantigenic contaminant or the denaturation of some of the protein during the 
iodination or fractionation procedures, or if both factors were involved. Similar 
studies were not carried out with the other DAM preparations used. 
Antigenic Relationships by Precipitin Analysis of Different DAM Preparations 
and between DAM and Amyloid.--The stronger of each pair  of antisera  was 
selected for studies to quantitate the relationship of different DAM preparations 
to each other and, in most instances, to the native amyloid preparations. Two 
approaches were used: quantitative precipitation and complement fixation. 
The results of quantitative precipitin analyses with four of the five antisera 
examined in detail are illustrated in Fig. 2. Because of lack of materials during 
certain phases of the study, it was not possible to compare each DAM prepara- 
tion with each of the antisera studied. 
As  expected,  each  antiserum  reacted  optimally with  the  antigen  used  for 
immunization; to a variable degree each reacted with most, but not always all, 
of the other preparations studied. None of the antisera gave a precipitate with 
NHS or a  saline extract of liver, spleen,  or kidney over a very wide range of 
concentration. Antisera 231,236,  and 242 showed significant degress of cross- 
reaction with  each of the DAM  preparations tested. Antiserum 213  failed to 
react with one of eight preparations tested, while antiserum 210  appeared to 
have a more limited specificity since it failed to react with five of eight DAM 
preparations by precipitin analyses. We further confirmed these studies with 
antiserum 213 by absorbing aliquots with DAM 1, 2, and 3, and then by testing 
the supernatants with DAM 2, the antigen used for immunization. In accord 
with the precipitin results, DAM  2 removed all the antibody, DAM  1 about 
33 %, and DAM 3 only negligible amounts. 
Because  of  the  insolubility  of  amyloid  in  physiological saline,  it  was  not 
possible to test the reactivity of the native protein with these antisera by pre- 
cipitin  analyses.  Consequently,  absorption  experiments were designed  to de- 
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the  region  of  antigen  excess  on  subsequent  ability  of  the antisera  to  pre- 
cipitate DAM.  Control experiments demonstrated that the addition of amyloid 
to an antiserum to 3'G  globulin did not affect the precipitation of 3'G  globulin 
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FIG. 2.  Precipitin  analyses  with various DAM preparations  and:  a,  Antiserum  210  to 
DAM l; b, Antiserum 212 to DAM 2; c,  Antiserum  231  to  DAM  5;  d,  Antiserum 242  to 
DAM 9. 
Antigens used in Figs.  2 and 3: DAM  1 t----®;  DAM 2  O----O;  DAM 3 A----A; 
DAM 5 [] .... D; DAM 6 •  at; DAM 8 A----A; DAM 9 A----A; DAM 10 D----[]. 
and,  therefore,  did  not  remove  an  unrelated  antibody.  As  shown  in Table  I, 
addition  of  amyloid 2  to  antiserum 213  completely removed  all  antibody  re- 
active with DAM  2,  thus showing that amyloid contained all of the antigenic 
determinants  present  in DAM.  Addition  of  amyloid  1  to  antiserum  210  and 
amyloid 6  to anti-DAM 236 resulted in a 55-75 ~7~ decrease in the amount pre- 
cipitated by the homologous DAM,  a  result which indicates a  significant, but EDWARD  C.  FRANKLIN  AND  MORDECHAI  I~RAS  803 
not complete, cross-reaction. In contrast, addition of amyloid 9 to antiserum 
242 removed less than 20% of the antibody. In the case of Amyloid 5, insuf- 
ficient amounts of material were available to carry out absorption studies. The 
results of these experiments are summarzed in Table I  and are compared to 
similar  comparative studies  of DAM  and  amyloid by  complement fixation. 
Antigenic  Rdationships  by  Complement  Fixation  between Different  DAM 
Preparations and between DAM and Amyloid.--Complement fixation was done 
to confirm and extend the results of the precipitin analyses. It was also done 
TABLE I 
Cross Reaction of Amyloid and DAM as Measured by the Absorption of Precipitating Antibody 
and by Complement Fixation 
C' Fixation~ 
Residual* 
Amyloid No.  Antiserum  Precipitate  %  Fixed  ~g AM 
~g D~  at peak 
% 
1  210  25; 45§  25  10 
2  213  0  100  5 
6  236  30  100  6 
9  242  80  ACII  -- 
#g ppt with absorbed AS  * % Residual precipitate -~  X 100. 
~g ppt with neat AS 
C'Hso fixed at peak by AM 
:I: %  Fixed ~  X  too. 
C'Hso fixed at peak by DAM 
§ 25% was the result obtained with the unlabeled preparation of DAM; 45% residual was 
estimated by measuring the 125I-labeled preparation. 
II AC, anticomplementary. 
because the  complement-fixation reaction can  be  carried  out with  insoluble 
antigens. Thus, since the interaction of the antisera and amyloid could be di- 
rectly measured by this  assay,  it  was  possible  to  compare,  by complement 
fixation, the cross-reaction between DAM and the amyloid from which it was 
prepared. 
Only one of the reagents (amyloid 9) proved to be anticomplimentary at the 
concentrations used. Fig. 3 shows the comparison of different preparations of 
DAM with the same four antisera to DAM shown in Fig. 2. In a  qualitative 
sense, the degree of cross-reaction noted by complement fixation was similar to 
that observed by precipitin analyses. However, minor inconsistencies were noted 
in several instances and cannot be explained at this time. Among these axe the 
greater reaction by complement fixation than by precipitation between DAM 5 
and 8  and antiserum 242; and the weak reaction between DAM 9  and anti- 
serum 231, and DAM 6, 8, and 9 and antiserum 210 respectively in the face of 100. 
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negative precipitin reactions. It seems possible that some of these discrepancies 
may reflect differences in the sensitivity of the two assays. 
The results of complement-fixation reaction between the antisera and intact 
amyloid also corresponded closely to those obtained by the inhibition of precipi- 
•  100  ¢  ..... 
.  ®  ® 
E. 
_  o  60 
b 
_  ~  40 
4/----  ~,' 
~,--~-f"  ....  /-  I  I  //I  //  I  I  I 
40  .so  120  160  200  a~o  3~0  40  ao  ~20  160  zoo 
//g ANTIGEN  //g ANTIGEN 
,oo 
E 
1-// 
80  c')  80 I  I 
X  ,~ 
X60  '=-6O  i~ 
~ 40  ~  ;I'/ I_A  c'~ 
20  20 ~- 
I  I  [  1  I  I  I 
40  80  120  160  40  80  120  160  200 
,Ug ANTIGEN  /,,'g ANTIGEN 
FIO. 3. Complement fixation with various DAM preparations and several amyloid prepara- 
tions, a Antiserum 210 to DAM  1; b Antiserum 212 to DAM 2; c Antiserum 231 to DAM 5; 
d  Antiserum 242  to  DAM  9.  Symbols  for DAMs--Same  as in Fig.  2.  Symbols  for AM  1 
eme  in Fig. 3  a; AM 2  e--e  in Fig. 3  b; AM 9 A  AC in Fig. 3  d. 
tation by the addition of intact amyloid to the antisera (Table I). In the case of 
amyloid 1, much larger amounts of amyloid than DAM were needed for every 
point on the curve, and the antigen never fixed more than 30% of the amount of 
complement fixed by DAM 1. In contrast, amyloid 2 and  amyloid 6 fixed as 
much complement as did the corresponding DAM. However, five to six times 
the amount of antigen were required to accomplish this. Similar studies could 
not be done with amyloid 5 for lack of material and with amyloid 9 because it 
proved to be anticomplementary. EDWARD  C.  FP,  A1WKI,IN AND  MORDECttAI  PRAS  805 
In only two patients was amyloid from different tissues available for  com- 
parative studies. In both instances, two cross-reacting antisera  revealed some 
differences in the reactivity of amyloids prepared from the spleen and kidney 
from the same subject. However, the amyloid from the spleen and kidney of the 
same individual bore a  closer resemblance to each other than they did to the 
amyloid prepared from the same organs of the other subject. Additional studies 
with pure preparations will be required to permit definitive conclusions on the 
identity or lack of identity of amyloid from different tissues of the same subject. 
Reaction of Antisera with Sera and  Urines from Patients with Amyloid, and 
Reaction of Sera  from These Patients with Amyloid.--Twelve sera and two urines 
were  available from patients  with  amyloidosis. Four  of these had  multiple 
myeloma and the remainder had either primary amyloidosis or secondary amy- 
loidosis associated with chronic infection. It seemed possible that their sera 
might contain products antigenlcaUy related to amyloid. However, none of the 
sera reacted with any of the antisera by double diffusion in agar. Conversely, 
the possibility existed that some of the sera might contain antibodies to amy- 
loid. Here, too, no precipitin reactions were noted when the sera were allowed to 
diffuse against each of the DAM preparations, including the one prepared from 
the patient whose serum was tested. Negative reactions were also obtained with 
three of the sera which contained myeloma proteins when they were tested with 
the patients' own DAM preparations. 
DISCUSSION 
One of the major conclusions from this study appears  to be that amyloid 
fibrils contain one or more antigenic substances which are not present in normal 
human serum or tissue. Because of the nature of the antigen and difficulties in 
obtaining clearcut results by double diffusion studies, it is not possible to deter- 
mine the precise number of antigenic constituents involved. An equally impor- 
tant result of this study is the failure to demonstrate any serum protein consti- 
tuents in these preparations of purified amyloid fibrils. When we compare these 
results, which at first glance appear contradictory to those previously reported 
in the literature (1-5), three points of difference must be considered. Firstly, the 
purified amyloid fibrils used in this study were thoroughly extracted with physi- 
ological saline to remove all soluble proteins. Thus, it seems possible that ~- 
globulins, c~-globuiins, and lipoproteins may all be intimately associated with 
the fibrils without being  integral constituents of the major fibrillar protein 
component of amyloid. Secondly, since the amyloid fibrils appear to be weak 
antigens (1-5),  it seems possible that they may not induce the formation of 
antibodies regularly when injected with other proteins.  Since it seems likely 
that none of the previous investigators had pure amyloid fibrils,  it is possible 
that antibody formation was induced by the associated proteins rather than the 
amyloid fibrils, and that antibody formation to the fibrils was inhibited by anti- 806  IM~IUNOLOGY  OF  AMYLOID 
genic competition.  Thirdly, the degradation of the amyloid fibrils by sodium 
hydroxide, and possibly by other agents, appears to have significantly increased 
the immunogenicity of the protein. 
The results  of this study, taken together with the preceding chemical anal- 
yses, permit certain tentative conclusions concerning the relations  of amyloid 
to DAM and of different DAM preparations to each other. Thus, different prep- 
arations of amyloid appear to share certain common characteristics,  yet to have 
others which appear to distinguish one preparation from the other. While one of 
the antisera appeared  to be very limited in its reactivity, most of the antisera 
reacted with most or all of the preparations of amyloid tested. The relatively 
high degree of purity of these preparations and the nature of the quantitative 
precipitin curves which cannot be explained readily by the presence of varying 
amounts of contaminants suggest  that these differences are indeed real and 
not due to contaminating substances.  It seems rather surprising  that the rel- 
atively great similarity in physical and chemical properties  between  different 
preparations of amyloid could  give rise  to the fairly marked immunological 
differences. However, the possibility exists that greater differences will become 
apparent once their primary structure is known. We can cite a precedent for 
this type of phenomenon in myeloma proteins which, in spite of their physical 
and chemical  similarities,  can have major differences by antigenic analysis. 
In myeloma proteins the magnitude of the differences in primary structure often 
does not become deafly apparent until amino acid sequence studies are per- 
formed,  or until sufficiently good antisera are available  to allow the demon- 
stration of classes and subclasses. The number of preparations of amyloid and 
antisera available  at this time does not permit any conclusions regarding  the 
existence of classes and subclasses of amyloid; in fact, the chemical and physical 
data in the previous  article  suggest this existence more strongly than do the 
immunologic studies. 
A few comments should be made on the immunogenicity of amyloid and the 
antigenic relationship  of amyloid and DAM. The results  of others,  taken with 
the few experiments cited in this article, would suggest that amyloid, like other 
fibrillar proteins,  is a poor antigen.  This feature may help to explain many of 
the results previously published. Once the fibril is degraded, however, it appears 
to become more  immunogenic. Whether this is related to its greater suscep- 
tibility to proteolysis in vivo or other as yet unknown factors remains obscure. 
The experiments, comparing the antigenic properties of amyloid and DAM and 
using the antisera to DAM, suggest that some of the determinants present in 
amyloid are either completely or partially hidden. Thus, they are not accessible 
to the antiserum. In one instance,  where amyloid was able to remove all the 
antibody reactive with DAM, five times the amount of antigen was required to 
reach equivalence, while in three others only a fraction of the potential deter- 
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The search for soluble 'precursors  of amyloid in serum and urine as well as 
attempts  to find antibodies to amyloid  in the sera of patients  were negative. 
However, additional studies with more sensitive methods appear warrantedto 
rule out these possibilities with absolute certainty.  Many  other questions  re- 
main to be answered, and many new approaches are potentially feasible as a re- 
sult  of  the  availability  of  antisera,  such  as  these.  Thus,  if  enough  different 
antisera and different preparations of amyloid are available, a clear-cut idea of 
the relation of amyloids from different patients and from different tissues from 
the samepatient would permit a more clear-cut classification of amy!old. Of even 
greater  importance,:  however,  is  the possibility  to localize amyloid  fibrils or 
their precursors within ceUs presumably involved in their synthesis.  Attempts 
to obtain information in these areas with light and electron microscopes are in 
progress (12). 
SUMMARY 
Eight preparations of soluble amyloid and degraded amyloid (DAM)  were 
compared immunologtcally. Unlike  amyloid fibrils,  six  of  eight preparations 
of DAM proved to be relatively strong immunogens. Antisera to DAM reacted 
weakly or not at all with normal human serum or extracts of normal tissues, 
but were specifically reactive with amyloid fibrils or DAM. 
Comparative studies of DAM's from eight different subjects showed some 
degree of cross-reactivity among them, yet demonstrated that they were not 
identical.  Similar  conclusions were  obtained  by  quantitative precipitin  and 
complement fixation analyses. 
Comparison of the amyloid fibrils with the homologous DAM  by comple- 
ment fixation and absorption studies demonstrated the existence in DAM of an- 
tigenic determinants that were lacking or inaccessible in the native fibrils. 
A search for amyloid precursors and antibodies to amyloid in the sera of 12 
patients proved unsuccessful, 
We would like to thank Miss Frances PreUi and Mr. Hiram Knott for their excellent 
technical assistance, and Mrs. Jane Bulger for secretarial help. 
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